Detalhe da pesquisa
1.
The Menin story in acute myeloid leukaemia-The road to success.
Br J Haematol
; 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38710595
2.
Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia.
Mol Cancer
; 22(1): 196, 2023 12 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38049829
3.
Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition.
Blood
; 136(21): 2442-2456, 2020 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32589720
4.
Next generation epigenetic modulators to target myeloid neoplasms.
Curr Opin Hematol
; 28(5): 356-363, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34267079
5.
Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax.
Haematologica
; 108(10): 2837-2843, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37102614
6.
Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with nucleophosmin1-mutated acute myeloid leukemia receiving gemtuzumab ozogamicin.
Haematologica
; 106(11): 2986-2989, 2021 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34047179
7.
Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia.
Blood
; 122(1): 100-8, 2013 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23704090
8.
High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations.
Blood
; 120(24): 4783-94, 2012 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23047824
9.
Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing.
Blood
; 120(18): e83-92, 2012 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22976956
10.
High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterations.
Blood
; 119(10): e67-75, 2012 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22234698
11.
Epigenetic targeting to enhance acute myeloid leukemia-directed immunotherapy.
Front Immunol
; 14: 1269012, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37809078
12.
Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial.
Lancet Haematol
; 10(7): e495-e509, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37187198
13.
Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia.
Blood Cancer J
; 12(4): 61, 2022 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35418180
14.
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications.
Blood Adv
; 6(18): 5345-5355, 2022 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35486475
15.
MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition.
Haematologica
; 100(5): e190-3, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25596271
16.
Genome-wide genotyping of acute myeloid leukemia with translocation t(9;11)(p22;q23) reveals novel recurrent genomic alterations.
Haematologica
; 99(8): e133-5, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24859875
17.
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia.
Cancer Discov
; 6(10): 1166-1181, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27535106
18.
Designed to kill: novel menin-MLL inhibitors target MLL-rearranged leukemia.
Cancer Cell
; 27(4): 431-3, 2015 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25873167
19.
Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
J Clin Oncol
; 31(1): 95-103, 2013 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23008312